Literature DB >> 26456361

Is There any Correlation Between Diabetic Retinopathy and Risk of Cardiovascular Disease?

Nasser Shoeibi, Shokoufeh Bonakdaran1.   

Abstract

BACKGROUND: There are growing evidence that indicate a relation between diabetic microangiopathy and cardiovascular disease with different mechanism.
OBJECTIVE: To investigate the association of diabetic retinopathy (DR) with the risk of cardiovascular disease (CVD) in type 2 diabetic patients.
METHODS: 180 type 2 diabetic patients who were free of CVD at baseline were enrolled. Patients were classified according to fundoscopy to no diabetic retinopathy (NDR), non proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR). CVD risk at 10 years was estimated using the UK Prospective Diabetes Study risk engine and patients were classified as high risk (20%), moderate risk (10-20%) and low risk (10%).
RESULTS: Prevalence of DR was 30.5%. Risk of CVD was significantly higher in PDR vs NDR (18.7±10.0% vs. 11.3±8.4%, p= 0.01) .The prevalence of NPDR (32% vs. 17.8%, p=0.002) and PDR (20% vs. 4.1%, p=0.04) was more in high risk group for CVD in comparison with low risk group for CVD. After adjustment for traditional risk factor for CVD, the risk for CVD remained markedly increased in the presence of DR.
CONCLUSION: DR is associated with estimated risk of CVD in type 2 diabetic patients. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Retinopathy; UKPDS risk score; cardiovascular disease; diabetes

Mesh:

Year:  2017        PMID: 26456361     DOI: 10.2174/1573399812666151012115355

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  5 in total

Review 1.  The prevalence of retinopathy among type 2 diabetic patients in Iran: A systematic review and meta-analysis.

Authors:  Masoud Mohammadi; Ali Akbar Vaisi Raiegani; Rostam Jalali; Akram Ghobadi; Nader Salari
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

Review 2.  Intravitreal anti-VEGF agents and cardiovascular risk.

Authors:  Massimo Porta; Elio Striglia
Journal:  Intern Emerg Med       Date:  2019-12-17       Impact factor: 3.397

3.  Effect of Chinese Patent Medicines on Ocular Fundus Signs and Vision in Calcium Dobesilate-Treated Persons With Non-Proliferative Diabetic Retinopathy: A Systematic Review and Meta-Analysis.

Authors:  Yuehong Zhang; Xuedong An; Liyun Duan; Yingying Duan; Rongrong Zhou; Yuqing Zhang; Xiaomin Kang; Fengmei Lian
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-14       Impact factor: 5.555

4.  Association Between Diabetic Retinopathy and Insomnia Risk: A Nationwide Population-Based Study.

Authors:  Yoo Hyun Um; Tae-Won Kim; Jong-Hyun Jeong; Seung-Chul Hong; Ho-Jun Seo; Kyung-Do Han
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

5.  Survival Time of Visual Gains after Diabetic Vitrectomy and Its Relationship with Ischemic Heart Disease.

Authors:  Abdah Khairiah Che Md Noor; Evelyn Li Min Tai; Yee Cheng Kueh; Ab Hamid Siti-Azrin; Zamri Noordin; Ismail Shatriah
Journal:  Int J Environ Res Public Health       Date:  2020-01-02       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.